.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advancements in dry eye managment

Marguerite McDonald, MD, Eric Donnenfeld, MD, Tracy Swartz, OD, MS, FAAO, and Crystal Brimer, OD, FAAO, discuss a number of topics pertaining to dry eye, including the diagnosis and clinical manifestations, traditional, treatment options, and the potential new agents in the horizon.

Latest News

Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient

Alcon completes acquisition of Aerie Pharmaceuticals

Words matter: Update how you talk to your patients

FDA approves intravenous injection for delayed onset of stage 3 type 1 diabetes

View More Latest News

Advancements in dry eye managment

EP. 1: Introduction and overview

EP. 2: Consequences and epidemiology of untreated dry eye

EP. 3: Diagnosis and overlooking asymptomatic patients with DED

EP. 4: Standard testing and assessment for DED

EP. 5: General Principles of Treatment of DED

EP. 6: OD and MD communication for optimal care

EP. 7: Review of artificial tears for DED

EP. 8: Corticosteroids and Immunomodulators for the treatment of dry eye

EP. 9: The role of nutritional supplements and antibiotics in DED

EP. 10: How to treat meibomian gland dysfunction

Latest News